These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19557199)

  • 1. Virus and host determinants of West Nile virus pathogenesis.
    Diamond MS
    PLoS Pathog; 2009 Jun; 5(6):e1000452. PubMed ID: 19557199
    [No Abstract]   [Full Text] [Related]  

  • 2. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b protein.
    Lucas M; Mashimo T; Frenkiel MP; Simon-Chazottes D; Montagutelli X; Ceccaldi PE; Guénet JL; Desprès P
    Immunol Cell Biol; 2003 Jun; 81(3):230-6. PubMed ID: 12752688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross.
    Green R; Wilkins C; Thomas S; Sekine A; Hendrick DM; Voss K; Ireton RC; Mooney M; Go JT; Choonoo G; Jeng S; de Villena FP; Ferris MT; McWeeney S; Gale M
    G3 (Bethesda); 2017 Jun; 7(6):1665-1682. PubMed ID: 28592649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [OAS genes and susceptibility to West Nile virus].
    Guénet JL; Després P
    Med Sci (Paris); 2003 Jan; 19(1):9-12. PubMed ID: 12836183
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.
    Graham JB; Thomas S; Swarts J; McMillan AA; Ferris MT; Suthar MS; Treuting PM; Ireton R; Gale M; Lund JM
    mBio; 2015 May; 6(3):e00493-15. PubMed ID: 25944860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis.
    Simon-Chazottes D; Frenkiel MP; Montagutelli X; Guénet JL; Desprès P; Panthier JJ
    Virology; 2011 Aug; 417(1):147-53. PubMed ID: 21683973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.
    Samuel MA; Diamond MS
    J Virol; 2006 Oct; 80(19):9349-60. PubMed ID: 16973541
    [No Abstract]   [Full Text] [Related]  

  • 8. Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production.
    Harioudh MK; Perez J; Chong Z; Nair S; So L; McCormick KD; Ghosh A; Shao L; Srivastava R; Soveg F; Ebert TS; Atianand MK; Hornung V; Savan R; Diamond MS; Sarkar SN
    Immunity; 2024 Mar; 57(3):446-461.e7. PubMed ID: 38423012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice.
    Mashimo T; Lucas M; Simon-Chazottes D; Frenkiel MP; Montagutelli X; Ceccaldi PE; Deubel V; Guenet JL; Despres P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11311-6. PubMed ID: 12186974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Correlates of Protection From West Nile Virus Neuroinvasion and Disease.
    Graham JB; Swarts JL; Thomas S; Voss KM; Sekine A; Green R; Ireton RC; Gale M; Lund JM
    J Infect Dis; 2019 Mar; 219(7):1162-1171. PubMed ID: 30371803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.
    Yakub I; Lillibridge KM; Moran A; Gonzalez OY; Belmont J; Gibbs RA; Tweardy DJ
    J Infect Dis; 2005 Nov; 192(10):1741-8. PubMed ID: 16235172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b.
    Mertens E; Kajaste-Rudnitski A; Torres S; Funk A; Frenkiel MP; Iteman I; Khromykh AA; Desprès P
    Virology; 2010 Mar; 399(1):176-185. PubMed ID: 20100623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chicken 2'-5' oligoadenylate synthetase A inhibits the replication of West Nile virus.
    Tag-El-Din-Hassan HT; Sasaki N; Moritoh K; Torigoe D; Maeda A; Agui T
    Jpn J Vet Res; 2012 Aug; 60(2-3):95-103. PubMed ID: 23094584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man.
    Lim JK; Lisco A; McDermott DH; Huynh L; Ward JM; Johnson B; Johnson H; Pape J; Foster GA; Krysztof D; Follmann D; Stramer SL; Margolis LB; Murphy PM
    PLoS Pathog; 2009 Feb; 5(2):e1000321. PubMed ID: 19247438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis.
    Cahill ME; Conley S; DeWan AT; Montgomery RR
    BMC Infect Dis; 2018 Jun; 18(1):282. PubMed ID: 29929468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host genetic variability and West Nile virus susceptibility.
    Samuel CE
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11555-7. PubMed ID: 12192094
    [No Abstract]   [Full Text] [Related]  

  • 17. A genetic basis for human susceptibility to West Nile virus.
    Diamond MS; Klein RS
    Trends Microbiol; 2006 Jul; 14(7):287-9. PubMed ID: 16750369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.
    Rios JJ; Fleming JG; Bryant UK; Carter CN; Huber JC; Long MT; Spencer TE; Adelson DL
    PLoS One; 2010 May; 5(5):e10537. PubMed ID: 20479874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.
    Lim JK; Louie CY; Glaser C; Jean C; Johnson B; Johnson H; McDermott DH; Murphy PM
    J Infect Dis; 2008 Jan; 197(2):262-5. PubMed ID: 18179388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.
    Glass WG; Lim JK; Cholera R; Pletnev AG; Gao JL; Murphy PM
    J Exp Med; 2005 Oct; 202(8):1087-98. PubMed ID: 16230476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.